Related Experiment Video
Updated: Nov 12, 2025

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Published on: August 1, 2013
Crimean-Congo Hemorrhagic Fever Virus (CCHFV): A Silent but Widespread Threat
Paul A Kuehnert1, Christopher P Stefan1, Catherine V Badger2
1Diagnostic Systems Division, US Army Medical Research Institute of Infectious Diseases, 1425 Porter St, Frederick, MD 21702 USA.
Purpose Of Review:
This review is aimed at highlighting recent research and articles on the complicated relationship between virus, vector, and host and how biosurveillance at each level informs disease spread and risk.
Recent Findings:
While human cases of CCHFV and tick identification in non-endemic areas in 2019-2020 were reported to sites such as ProMed, there is a gap in recent published literature on these and broader CCHFV surveillance efforts from the late 2010s.
Summary:
A review of the complex aspects of CCHFV maintenance in the environment coupled with high fatality rate and lack of vaccines and therapeutics warrants the need for a One-Health approach toward detection and increased biosurveillance programs for CCHFV.
Related Concept Videos
Subviral Agents
Viral Recombination
Viruses with RNA Genomes

